Related Experiment Video

Updated: Aug 22, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

S-adenosylmethionine and Pneumocystis

Salim Merali1, Allen Boykin Clarkson

  • 1Department of Medical and Molecular Parasitology, New York University School of Medicine, 341 East 25th Street, New York, NY, USA. merals01@med.nyu.edu

FEMS Microbiology Letters
|August 24, 2004
PubMed

Insights

Pneumocystis fungi cannot produce S-adenosylmethionine (AdoMet), requiring hosts for this vital metabolite. Depleting host AdoMet, even with nicotine, shows therapeutic potential against Pneumocystis pneumonia.

Area of Science:

  • Medical Mycology
  • Parasitology
  • Metabolic Biochemistry

Background:

  • Pneumocystis fungi are opportunistic pathogens causing pneumonia in immunocompromised individuals.
  • S-adenosylmethionine (AdoMet) is an essential metabolite for all cells, crucial for methylation and other metabolic pathways.
  • Pneumocystis is uniquely incapable of synthesizing AdoMet, unlike most organisms.

Purpose of the Study:

  • To investigate the metabolic dependency of Pneumocystis on host-derived AdoMet.
  • To explore the diagnostic and therapeutic implications of AdoMet depletion in Pneumocystis pneumonia (PcP).

Main Methods:

  • Utilized a Pneumocystis culture system to identify its inability to synthesize AdoMet.
  • Measured AdoMet levels in animal plasma following Pneumocystis infection.
  • Assessed the therapeutic effect of reducing host lung AdoMet via nicotine treatment in a rat model of PcP.

Main Results:

  • Confirmed Pneumocystis's inability to synthesize AdoMet, necessitating host acquisition.
  • Observed significant depletion of AdoMet in the plasma of infected animals.
  • Demonstrated that AdoMet depletion in host lungs correlates with PcP.
  • Preliminary data suggest nicotine treatment, reducing host AdoMet, is therapeutic in a rat PcP model.

Conclusions:

  • Pneumocystis's reliance on host AdoMet presents a unique metabolic vulnerability.
  • AdoMet depletion in PcP patients may serve as a diagnostic marker and indicator of treatment efficacy.
  • Targeting host AdoMet levels represents a potential novel therapeutic strategy for PcP.

More Related Videos

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay09:20

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...